AstraZeneca Q3 profit beats estimates as cancer drug sales drive growth
AstraZeneca Q3 profit beats estimates as cancer drug sales drive growth(摘要待生成)
AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026 outlook
AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026 outlook(摘要待生成)
Astrazeneca (AZN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Zacks Investment Research
Astrazeneca (AZN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Zacks Investment Research(摘要待生成)
AZN Q3 Earnings Beat Estimates, Oncology Drugs Drive Sales Growth - Zacks Investment Research
AZN Q3 Earnings Beat Estimates, Oncology Drugs Drive Sales Growth - Zacks Investment Research(摘要待生成)
SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus - Yahoo Finance
SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus - Yahoo Finance(摘要待生成)
AstraZeneca (AZN) Q3 2026 Earnings Call Transcript
AstraZeneca (AZN) Q3 2026 Earnings Call Transcript(摘要待生成)
AstraZeneca Q3 Earnings Call Highlights - Yahoo Finance
AstraZeneca Q3 Earnings Call Highlights - Yahoo Finance(摘要待生成)
Update: AstraZeneca Q3 Adjusted Earnings, Revenue Rise; Reaffirms 2026 Outlook - Yahoo Finance
Update: AstraZeneca Q3 Adjusted Earnings, Revenue Rise; Reaffirms 2026 Outlook - Yahoo Finance(摘要待生成)
AstraZeneca acquires preclinical biotech Omniose
AstraZeneca acquires preclinical biotech Omniose(摘要待生成)
BSC and AstraZeneca Sign Agreement to Advance AI and Supercomputing Applied to Healthcare
BSC and AstraZeneca Sign Agreement to Advance AI and Supercomputing Applied to Healthcare(摘要待生成)
AstraZeneca Secures Dual Rare Disease and Bladder Cancer Approvals Across US, Europe - Benzinga
AstraZeneca Secures Dual Rare Disease and Bladder Cancer Approvals Across US, Europe - Benzinga(摘要待生成)
AstraZeneca gets U.S. approval for two drugs
AstraZeneca gets U.S. approval for two drugs(摘要待生成)
AZN Jumps As AstraZeneca Delivers Big Oncology Wins - StocksToTrade
AZN Jumps As AstraZeneca Delivers Big Oncology Wins - StocksToTrade(摘要待生成)
AstraZeneca: 3 Key Takeaways for Long-Term Investors
AstraZeneca: 3 Key Takeaways for Long-Term Investors(摘要待生成)